T-3775440

CAS No. 1422620-34-5

T-3775440( T 3775440 | T3775440 )

Catalog No. M11775 CAS No. 1422620-34-5

T-3775440 is a novel potent, selecitve, irreversible LSD1 inhibitor with IC50 of 2.1 nM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    T-3775440
  • Note
    Research use only, not for human use.
  • Brief Description
    T-3775440 is a novel potent, selecitve, irreversible LSD1 inhibitor with IC50 of 2.1 nM.
  • Description
    T-3775440 is a novel potent, selecitve, irreversible LSD1 inhibitor with IC50 of 2.1 nM; displays high selectivity for LSD1 relative to other monoamine oxidases (e.g., MAO-A and MAO-B); disrupts the interaction between LSD1 and growth factor-independent 1B (GFI1B) in leukemia cell lines, exhibites significant antitumor efficacy in AEL and AMKL xenograft models.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    T 3775440 | T3775440
  • Pathway
    Chromatin/Epigenetic
  • Target
    Histone Demethylase
  • Recptor
    Histone Demethylase
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1422620-34-5
  • Formula Weight
    310.401
  • Molecular Formula
    C18H22N4O
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CN1C=C(C=N1)C(=O)NC2=CC=C(C=C2)C3CC3NCC4CC4
  • Chemical Name
    N-(4-((1S,2R)-2-((cyclopropylmethyl)amino)cyclopropyl)phenyl)-1-methyl-1H-pyrazole-4-carboxamide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Takagi S, et al. Cancer Res. 2017 Jun 30. pii: canres.3502.2016. 2. Ishikawa Y, et al. Mol Cancer Ther. 2017 Feb;16(2):273-284.
molnova catalog
related products
  • Dot1L-IN-4

    Dot1L-IN-4 is a potent disruptor of telomeric silencing 1-like protein (DOT1L) inhibitor.

  • GSK J4 hydrochloride

    GSK J4 HCl is a cell permeable prodrug of GSK J1, which is the first selective inhibitor of the H3K27 histone demethylase JMJD3 and UTX with IC50 of 60 nM.

  • 3-pyridine toxoflavi...

    3-pyridine toxoflavin is a potent KDM4C inhibitor, IC50=19nM.